India 2011 © Anna Surinyach/MSF
Previously, kala azar patients were given the drug SSG, which required a long and toxic treatment. Many people in India and Bangladesh developed resistance to SSG. The current drug used to treat the disease is effective, requires a short course of treatment, and has fewer side effects. The initial cure rate at MSF's project in Sadar Hospital is 98 percent.